A postgraduate research scholarship
|Value||Eligibility||Open date||Close date|
|$40,000 p.a. (up to 3.5 years)||
||15 July 2021||30 September 2021|
How to apply
This scholarship is valued at $40,000 per annum and is tenable for up to 3.5 years.
- be an Australian Citizen, Australian Permanent Resident or hold an appropriate visa that provides residency status and the right to work in Australia until the later of the 30 August 2023 or the projected conclusion of your PhD candidature
- be willing to apply for admission, apply for admission or have a conditional or unconditional offer of admission to commence in a full-time PhD within the Faculty of Medicine and Health
- conduct research as part of a project named, ‘Development of a universal gene therapy approach using CRISPR-based genome editing technology to treat pediatric liver disease.’
- be able to demonstrate you hold an undergraduate degree with at least a credit average or equivalent and have either:
- research experience through an honors program (First Class or Second Class, Division I), or
- a Masters’s Degree by Research in a relevant subject.
Preference will be given to applicants who can demonstrate they have experience in one or more of the following:
- molecular cloning
- tissue culture
- animal handling
- vector production, and/or
- immunofluorescence and immunohistochemistry.
This scholarship is funded by New South Wales (NSW) Health and the University of Sydney as part of the NSW Health Gene and Cell Therapy Ph.D. Program.
COURTESY – UNIVERSITY OF SYDNEY